Galunisertib Drives Treg Fragility and Promotes Dendritic Cell-Mediated Immunity against Experimental Lymphoma.

iScience · 2020 · PMC7559877 · PMID 33089111

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

However, in vivo treatment did not produce highly significant impact on the DL tumor-bearing mice with respect to survival or reduction in tumor size including the clearance of the tumor and recurrence.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.